---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043330"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:05:36.758557+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharmaceuticals secures $1.2M in new loans; issues warrants and amends existing debt

## Summary
- Entered Bridge Loan with A.G.P. for up to $600k at 4.21% due Dec 31, 2024; issued warrants for 2.86M shares at $0.1048 per share, subject to shareholder approval.
- Issued $600k promissory note to Nirland Limited at 12% per annum, maturing Oct 31, 2025; includes 1% arrangement fee.
- Amended prior $2.65M Nirland note to allow conversion to common stock and removed mandatory prepayment and right of first refusal.
- Proceeds from ATM offering of up to ~$3.5M will be used first to repay the A.G.P. Bridge Note.
- Warrants and conversion shares are unregistered, issued under Section 4(a)(2) exemption.

## SEC filing metadata
- accession: 0001493152-24-043330
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315224043330/0001493152-24-043330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315224043330/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043330
- JSON: https://secwatch.observer/filing/0001493152-24-043330.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.